Abiy Habtewold
- Virology top 5%
- HIV Research and Treatment 7
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection 6
- Pharmacogenetics and Drug Metabolism 4
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 11
- Tuberculosis Research and Epidemiology 4
- Hepatology top 10%
-
- Drug Transport and Resistance Mechanisms 6
-
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- HIV-related health complications and treatments 4
In The Last Decade
Abiy Habtewold
24 papers receiving 716 citations
Peers
Comparison fields: 5 of 72
- Virology 158
- Pharmacology 277
- Infectious Diseases 361
- Hepatology 81
- Pediatrics, Perinatology and Child Health 116
Countries citing papers authored by Abiy Habtewold
This map shows the geographic impact of Abiy Habtewold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abiy Habtewold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abiy Habtewold more than expected).
Fields of papers citing papers by Abiy Habtewold
This network shows the impact of papers produced by Abiy Habtewold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abiy Habtewold. The network helps show where Abiy Habtewold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abiy Habtewold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2020 | 16 | |
| 3 | 2018 | 3 | |
| 4 | 2017 | 13 | |
| 5 | 2017 | 27 | |
| 6 | 2017 | 10 | |
| 7 | 2016 | 13 | |
| 8 | 2016 | 38 | |
| 9 | 2016 | 24 | |
| 10 | 2015 | 23 | |
| 11 | 2014 | 46 | |
| 12 | 2013 | 15 | |
| 13 | 2013 | 14 | |
| 14 | 2013 | 22 | |
| 15 | 2013 | 107 | |
| 16 | 2012 | 32 | |
| 17 | 2012 | 41 | |
| 18 | 2011 | 84 | |
| 19 | 2011 | 52 | |
| 20 | 2011 | 93 |
About Abiy Habtewold
Abiy Habtewold is a scholar working on Virology, Pharmacology and Infectious Diseases, having authored 25 papers that have together received 728 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Tuberculosis Research and Epidemiology (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Virology (158 citations), Pharmacology (277 citations) and Infectious Diseases (361 citations). Abiy Habtewold has collaborated with scholars based in Ethiopia, Sweden and Germany. Frequent co-authors include Eleni Aklillu, Getnet Yimer, Eyasu Makonnen, Wondwossen Amogne, Getachew Aderaye, Jürgen Burhenne, Lars Lindquist, Leif Bertilsson, Sabina Mugusi and Klaus‐Dieter Riedel. Their work appears in journals such as PLoS ONE, Scientific Reports, The Pharmacogenomics Journal, Frontiers in Pharmacology and OMICS A Journal of Integrative Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.